help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaptein, E. M.
Right arrow Articles by Nicoloff, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaptein, E. M.
Right arrow Articles by Nicoloff, J. T.

Journal of Clinical Endocrinology & Metabolism, Vol 51, 488-491, Copyright © 1980 by Endocrine Society


ARTICLES

Effects of prolonged dopamine infusion on anterior pituitary function in normal males

EM Kaptein, OA Kletzky, CA Spencer and JT Nicoloff

The influence of a 48-h dopamine (DA) infusion (5-7.5 micrograms/kg.min) on serum PRL, TSH, LH, FSH, and GH values was determined in six normal adult males. Sustained suppression of serum PRL to 78% (P less than 0.01) below baseline levels during DA was followed by an acute rebound of 319% (P less than 0.01) 4 h after stopping DA. Similarly, TSH decreased by 44% during DA but had a more gradual and sustained rebound of 41% (P less than 0.01) over a 36-h period. While both serum LH and FSH initially dropped by 25% (P less than 0.001) and 10% (P less than 0.05), a gradual escape occurred during the DA infusion, followed by rebounds of 23% (P less than 0.01), respectively. A brief rise in serum GH levels occurred with DA treatment, followed by a return to baseline. Subsequently, oscillatory spikes continued throughout the DA infusion but were significantly decreased (P less than 0.01) after stopping DA. Thus, DA administration initially produced a reduction in serum PRL, TSH, LH and PSH while stimulating GH release. PRL and TSH showed a sustained inhibition, whereas LH and FSH progressively escaped after a lesser degree of suppression by DA. The rebound after DA withdrawal probably reflected the discharge of hormone synthesized and stored during DA administration. The inverse relationship between the nadir of inhibition and the peak rebound values (r = 0.92) supports this hypothesis. Clearly, the patterns of serum LH, FSH, and GH values differ with acute and chronic DA administration. These differences are of potential importance in interpreting dopaminergic influences on anterior pituitary function.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society